5 years ago 1 min read AstraZeneca Plc paused its late-stage study after a person participating in the trial became ill. Shares of Chinese vaccine makers plunged in Asian trading. Continue Reading Previous Global food prices have been rising during the coronavirus pandemic, hitting food securityNext New report finds Covid-19 pandemic is jeopardizing decades of work in reducing preventable childhood deaths Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment. More Stories For Your Health 1 min read Record Korean Cases; Trader’s Guide to Rollout: Virus Update 5 years ago For Your Health 1 min read California Hits Record; Trader’s Guide to Rollout: Virus Update 5 years ago For Your Health 1 min read AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push 5 years ago
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push